DAVITA INC. (DVA) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
43/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinDVA / S&P 44.76% / 15.20% |
LoseDVA / S&P 6.45% / 15.00% |
LoseDVA / S&P 19.70% / 50.40% |
| 2026-Q11/3 |
WinDVA / S&P 35.28% / -4.33% |
LoseDVA / S&P 6.68% / 11.30% |
LoseDVA / S&P 6.36% / 27.70% |
| 2025-Q40/3 |
LoseDVA / S&P -14.50% / 2.65% |
LoseDVA / S&P 6.46% / 9.00% |
LoseDVA / S&P -8.21% / 13.40% |
| 2025-Q31/3 |
LoseDVA / S&P -6.73% / 8.12% |
WinDVA / S&P 5.14% / 4.61% |
LoseDVA / S&P 4.53% / 13.45% |
| 2025-Q21/3 |
LoseDVA / S&P -6.88% / 10.94% |
WinDVA / S&P 5.09% / 4.83% |
LoseDVA / S&P 8.09% / 10.63% |
| 2025-Q13/3 |
WinDVA / S&P 2.29% / -4.27% |
WinDVA / S&P 5.11% / 4.98% |
WinDVA / S&P 14.43% / 10.57% |
| 2024-Q42/3 |
LoseDVA / S&P -8.77% / 2.41% |
WinDVA / S&P 5.56% / 5.25% |
WinDVA / S&P 44.86% / 6.15% |
| 2024-Q33/3 |
WinDVA / S&P 18.30% / 5.89% |
WinDVA / S&P 6.34% / 5.89% |
WinDVA / S&P 41.31% / 6.11% |
| 2024-Q22/3 |
LoseDVA / S&P 0.38% / 4.28% |
WinDVA / S&P 6.69% / 5.38% |
WinDVA / S&P 85.21% / 5.12% |
| 2024-Q13/3 |
WinDVA / S&P 31.78% / 10.56% |
WinDVA / S&P 5.77% / 5.71% |
WinDVA / S&P 61.17% / 5.59% |
| 2023-Q41/3 |
LoseDVA / S&P 10.82% / 11.69% |
LoseDVA / S&P 4.57% / 6.81% |
WinDVA / S&P 27.15% / 7.78% |
| 2023-Q31/3 |
LoseDVA / S&P -5.91% / -3.27% |
LoseDVA / S&P 2.36% / 7.52% |
WinDVA / S&P -4.37% / -5.03% |
| 2023-Q21/3 |
WinDVA / S&P 23.87% / 8.74% |
LoseDVA / S&P 0.96% / 9.50% |
LoseDVA / S&P -37.33% / -8.57% |
| 2023-Q11/3 |
WinDVA / S&P 8.62% / 7.50% |
LoseDVA / S&P 0.42% / 10.77% |
LoseDVA / S&P -35.23% / -15.69% |
| 2022-Q40/3 |
LoseDVA / S&P -9.79% / 7.56% |
LoseDVA / S&P -0.08% / 11.88% |
LoseDVA / S&P -34.68% / -17.99% |
| 2022-Q31/3 |
WinDVA / S&P 3.51% / -4.88% |
LoseDVA / S&P 5.13% / 13.47% |
LoseDVA / S&P -20.23% / -1.41% |
| 2022-Q20/3 |
LoseDVA / S&P -29.31% / -16.10% |
LoseDVA / S&P 5.17% / 13.71% |
LoseDVA / S&P 7.58% / 11.04% |
| 2022-Q11/3 |
WinDVA / S&P -0.57% / -4.60% |
LoseDVA / S&P 5.43% / 15.97% |
LoseDVA / S&P 29.69% / 42.23% |
| 2021-Q40/3 |
LoseDVA / S&P -2.15% / 11.03% |
LoseDVA / S&P 5.25% / 15.00% |
LoseDVA / S&P 41.43% / 96.40% |
| 2021-Q30/3 |
LoseDVA / S&P -3.46% / 0.58% |
LoseDVA / S&P -3.01% / 10.77% |
LoseDVA / S&P 31.10% / 69.42% |
| 2021-Q21/3 |
WinDVA / S&P 11.75% / 8.55% |
LoseDVA / S&P -1.91% / 6.58% |
LoseDVA / S&P 20.71% / 51.81% |
| 2021-Q11/3 |
LoseDVA / S&P -8.20% / 6.17% |
WinDVA / S&P -0.95% / -1.06% |
LoseDVA / S&P 4.00% / 7.39% |
| 2020-Q43/3 |
WinDVA / S&P 37.07% / 12.15% |
WinDVA / S&P 1.11% / -3.72% |
WinDVA / S&P 19.77% / -33.42% |
| 2020-Q32/3 |
LoseDVA / S&P 8.23% / 8.93% |
WinDVA / S&P 4.90% / -2.04% |
WinDVA / S&P 148.48% / -27.10% |
| 2020-Q22/3 |
LoseDVA / S&P 4.05% / 20.54% |
WinDVA / S&P 4.65% / -0.46% |
WinDVA / S&P 616.09% / -27.11% |
| 2020-Q12/3 |
WinDVA / S&P 1.37% / -19.60% |
LoseDVA / S&P 3.44% / 3.47% |
WinDVA / S&P 722.37% / -14.75% |
| 2019-Q42/3 |
WinDVA / S&P 31.47% / 9.07% |
LoseDVA / S&P 1.95% / 5.36% |
WinDVA / S&P 526.19% / 2.99% |
| 2019-Q30/3 |
LoseDVA / S&P 1.44% / 1.70% |
LoseDVA / S&P 2.69% / 5.02% |
LoseDVA / S&P -20.00% / 0.21% |
| 2019-Q20/3 |
LoseDVA / S&P 3.63% / 4.30% |
LoseDVA / S&P 2.71% / 6.64% |
LoseDVA / S&P -71.00% / 8.65% |
| 2019-Q10/3 |
LoseDVA / S&P 5.50% / 13.65% |
LoseDVA / S&P 4.80% / 8.12% |
LoseDVA / S&P -64.15% / 14.29% |
| 2018-Q40/3 |
LoseDVA / S&P -28.16% / -13.52% |
LoseDVA / S&P DVA unavailable / 9.05% |
LoseDVA / S&P -75.51% / 18.23% |
| 2018-Q31/3 |
LoseDVA / S&P 3.15% / 7.71% |
LoseDVA / S&P DVA unavailable / 10.21% |
WinDVA / S&P 25.48% / 19.06% |
| 2018-Q21/3 |
WinDVA / S&P 5.31% / 3.43% |
LoseDVA / S&P DVA unavailable / 9.03% |
LoseDVA / S&P -53.92% / 14.46% |
| 2018-Q10/3 |
LoseDVA / S&P -8.73% / -0.76% |
LoseDVA / S&P DVA unavailable / 7.68% |
LoseDVA / S&P -65.36% / 12.46% |
| 2017-Q41/3 |
WinDVA / S&P 21.65% / 6.64% |
LoseDVA / S&P DVA unavailable / 7.03% |
LoseDVA / S&P -20.23% / 13.82% |
| 2017-Q30/3 |
LoseDVA / S&P -8.29% / 4.48% |
LoseDVA / S&P DVA unavailable / 5.68% |
LoseDVA / S&P -24.21% / 17.57% |
| 2017-Q21/3 |
LoseDVA / S&P -4.72% / 3.09% |
LoseDVA / S&P DVA unavailable / 4.83% |
WinDVA / S&P 280.70% / 17.74% |
| 2017-Q11/3 |
LoseDVA / S&P 5.87% / 6.07% |
LoseDVA / S&P DVA unavailable / 3.67% |
WinDVA / S&P 174.44% / 13.32% |
| 2016-Q41/3 |
LoseDVA / S&P -2.83% / 3.82% |
LoseDVA / S&P DVA unavailable / 2.09% |
WinDVA / S&P 246.77% / 7.05% |
| 2016-Q31/3 |
LoseDVA / S&P -14.55% / 3.85% |
LoseDVA / S&P DVA unavailable / 0.20% |
WinDVA / S&P 57.01% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | DVA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 29.85% | 20.78% |
| Annualized return | 29.85% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | DVA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 36.79% | 83.14% |
| Annualized return | 6.47% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | DVA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 178.67% | 319.30% |
| Annualized return | 10.79% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |